Plain-English translation of NCT07626489 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether injecting ropivacaine (a numbing medication) mixed with Diprospan (a steroid) into the surgical incision before lung surgery can better prevent pain after the operation. About 80% of patients still experience significant pain after this type of lung surgery, even though it's minimally invasive. The study wants to see if adding the steroid helps the numbing medication work longer and reduce inflammation, keeping you more comfortable as you recover.
After lung surgery, many patients develop acute pain that can lead to serious complications and even chronic pain lasting months. While numbing medications injected at the incision help, their effect doesn't last long enough. This medication combines two approaches—numbing plus anti-inflammatory action—to see if it can keep patients comfortable longer and prevent pain from becoming a long-term problem.
You likely qualify if…
You likely don't qualify if…
If you join this study, before your scheduled lung surgery, you'll receive an injection of numbing medication with or without the steroid into the area around your planned incision. One group will receive the medication combination, and the other group will receive the numbing medication alone (you won't know which one you're getting). After surgery, you'll be asked to rate your pain at regular intervals during your hospital stay and at follow-up visits, helping doctors understand how well the treatment works.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
China